According to researchers at Semmelweis University, not only inflammation, but also sleep disorders, depression, obesity, and ...
Tom Nolan reviews this week’s research A trial of testosterone therapy in men used the PDQ-Q4 score to quantify sexual ...
NewLimit’s lead liver combo has proven its worth in preclinical models, Kimmel told Fierce, with the ability to boost ...
A large case-control study found that adverse drug effects in patients with autoimmune rheumatologic diseases were more ...
She’d diagnosed rheumatoid arthritis dozens of times but dismissed her own symptoms and fought her eventual diagnosis. Today ...
Scholar's quiet legacy becomes a $10 million gift.
Magnetic resonance imaging emerged as a key diagnostic tool. Characteristic findings included hypointense rice bodies within ...
First Tracks launched April 20th with a two-year cash-runway to advance ANB033 through celiac disease and eosinophilic esophagitis Phase 1b data ...
Just because a company invests does not mean it has invented anything novel,” Tahir Amin and Rohit Malpani write in this ...
Discusses Positive Interim Results From JADE101 Phase I Healthy Volunteer Study and Development Plans June 1, 2026 8:00 ...
Nipocalimab - the first neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus - is designed to target and reduce pathogenic immunoglobulin G (IgG) autoantibodies associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results